Abstract
In this paper, we examine the relation between a firm’s research and development (R & D) intensity and dividend payout policy with a focus on biotech firms in a sample of 18,253 firm-year observations in South Korea. We find that biotech firms’ R & D intensity is negatively related to dividend payout. Furthermore, for biotech firms, increased internal cash holding accomplished via a lower dividend policy is positively associated with long-term corporate value. In particular, this study reports that the relation between biotech firms’ cash holding and corporate firm value is significantly positive in firms with high stock dividends. Moreover, it shows that non-biotech firms in the maturity stage of the corporate lifecycle tend to distribute cash dividends, a practice that is relatively uncommon among biotech firms in an R & D steady state.
Subject
Management, Monitoring, Policy and Law,Renewable Energy, Sustainability and the Environment,Geography, Planning and Development
Reference86 articles.
1. International Purchasing and Global Sourcing - What are the Differences?
2. What is the right supply chain for your product?;Fisher;Harv. Bus. Rev.,1997
3. Explaining dividend gap between R&D and non-R&D Indian companies in the post reform period;Lahiri;Res. Int. Bus. Financ.,2014
4. Payout Policy in Korea: A Review of Empirical Evidence;Kim;Asian Rev. Financ. Res.,2011
5. BizChosunhttp://biz.chosun.com/site/data/html_dir/2018/01/12/2018011200856.html
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献